Gene · 8739
Papers1,778
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 1,778
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 33617479 | PubTator, text mining | PubMed |
| Long Noncoding RNA SOX2-OT Aggravates Doxorubicin-Induced Apoptosis of Cardiomyocyte by Targeting miR-942-5p/DP5. | Drug Des Devel Ther | 2021 | 33603338 | PubTator, text mining | PubMed |
| Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. | Cancer Discov | 2021 | 33593877 | PubTator, text mining | PubMed |
| Targeting critical kinases and anti-apoptotic molecules overcomes steroid resistance in MLL-rearranged leukaemia. | EBioMedicine | 2021 | 33581643 | PubTator, text mining | PubMed |
| Prospective randomized pharmacogenetic study of topiramate for treating alcohol use disorder. | Neuropsychopharmacology | 2021 | 33568796 | PubTator, text mining | PubMed |
| Beneficial Actions of Orostachys japonica and Its Compounds against Tumors via MAPK Signaling Pathways. | Nutrients | 2021 | 33567572 | PubTator, text mining | PubMed |
| Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial. | Neuropsychopharmacology | 2021 | 33558678 | PubTator, text mining | PubMed |
| The combined effect of long working hours and individual risk factors on cardiovascular disease: An interaction analysis. | J Occup Health | 2021 | 33556993 | PubTator, text mining | PubMed |
| How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? | Hepatol Int | 2021 | 33548031 | PubTator, text mining | PubMed |
| The versatile role of exosomes in human retroviral infections: from immunopathogenesis to clinical application. | Cell Biosci | 2021 | 33451365 | PubTator, text mining | PubMed |
| Some Molecular and Cellular Stress Mechanisms Associated with Neurodegenerative Diseases and Atherosclerosis. | Int J Mol Sci | 2021 | 33445687 | PubTator, text mining | PubMed |
| Targeting Glioblastoma: The Current State of Different Therapeutic Approaches. | Curr Neuropharmacol | 2021 | 33441071 | PubTator, text mining | PubMed |
| PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors. | Cell Commun Signal | 2021 | 33430890 | PubTator, text mining | PubMed |
| Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea. | Cancer Res Treat | 2021 | 33421973 | PubTator, text mining | PubMed |
| Melatonin inhibiting the survival of human gastric cancer cells under ER stress involving autophagy and Ras-Raf-MAPK signalling. | J Cell Mol Med | 2021 | 33369155 | PubTator, text mining | PubMed |
| Impact and effectiveness of a conjugate vaccine against invasive pneumococcal disease in Finland - a modelling approach. | Hum Vaccin Immunother | 2021 | 33327857 | PubTator, text mining | PubMed |
| On the nature of ceramide-mitochondria interactions - Dissection using comprehensive mitochondrial phenotyping. | Cell Signal | 2021 | 33212155 | PubTator, text mining | PubMed |
| BCL2‑regulated apoptotic process in myocardial ischemia‑reperfusion injury (Review). | Int J Mol Med | 2021 | 33155658 | PubTator, text mining | PubMed |
| Downregulation of ARID1A in gastric cancer cells: a putative protective molecular mechanism against the Harakiri-mediated apoptosis pathway. | Virchows Arch | 2021 | 32789692 | PubTator, text mining | PubMed |
| Mechanisms of neuroplasticity and brain degeneration: strategies for protection during the aging process. | Neural Regen Res | 2021 | 32788448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8739/papers?page=29